| 摘要 |
A pharmaceutical composition for treatment of overweight and obesity or complications thereof, the composition comprising a combination of an adrenerg beta agonist and a xanthine, e.g. a combination of ephedrine and caffeine, in a weight ratio from about 1:8 to about 1:24, calculated (when the beta agonist is not L-ephedrine) on the isothermogenic amount of L-epherdrine and (when the xanthine is not caffeine) on the isothermogenic amount of caffeine to obtain a supraadditive thermogenic effect in the body after oral, rectal, nasal or parenteral administration. The composition can furthermore be used in a domestic animal with the purpose of improving the body content of meat at the expense of the body content of fat. |
